Advanced Cell Technology to Host Conference Call and Webcast to Provide a Corporate Update for the Third Quarter of 2014
November 07 2014 - 9:09AM
Business Wire
Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in
the field of regenerative medicine, announced today that the
company will host a conference call on Monday, November 10, 2014 at
4:30 p.m. EST during which it will provide a corporate update for
the third quarter of 2014.
Interested parties may access the call live by dialing (888)
264-3177 and using conference ID 87191640.
This event is also being streamed via webcast. The webcast is
available at
http://engage.vevent.com/rt/act~advancedcelltechnology111014. A
replay of the call will also be available via the same link for 90
days.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a Marlborough, Mass.-based
biotechnology company focused on the development and
commercialization of novel cell-based therapies. ACT’s therapeutic
area of focus is ophthalmology and the Company’s most advanced
products are in clinical trials for the treatment of dry
age-related macular degeneration, Stargardt’s macular degeneration
and myopic macular degeneration. The Company is also developing
several pre-clinical cell therapies for the treatment of other
ocular disorders. Additionally, the Company also has a number of
pre-clinical stage assets in disease areas outside the field of
ophthalmology, including autoimmune, inflammatory and wound
healing-related disorders. For more information, visit
www.advancedcell.com
Contact:Investors:Westwicke PartnersJohn Woolford,
443-213-0506orPress:Russo PartnersDavid Schull, 858-717-2310